Mirum Pharmaceuticals Inc (MIRM) — Capital Reinvestment Ratio
Mirum Pharmaceuticals Inc (MIRM) has a Capital Reinvestment Ratio of 0.10x as of December 2025, meaning it reinvests 0% of its operating cash flow ($6.07 Million) in capital expenditures ($600.00K). See MIRM net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mirum Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Mirum Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does Mirum Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc from 2024 to 2025. For live market cap and broader valuation context, see Mirum Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $55.83 Million | $954.00K | ▼ -82.2% |
| 2024 | 0.10x | $10.32 Million | $993.00K | — |